Clinical trial
N-acetylcysteine Reduces Acetaldehyde Levels in Binge Alcohol Drinking
NCT05911282 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-acetylcysteine Reduces Acetaldehyde Levels in Binge Alcohol Drinking
- Lead sponsor
- University Medical Centre Ljubljana
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2021
- Completion date
- June 30, 2021
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ethanol intoxication